We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+1.7%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$353M
AUM Growth
-$38.5M
Cap. Flow
-$19.5M
Cap. Flow %
-5.52%
Top 10 Hldgs %
29.86%
Holding
76
New
2
Increased
32
Reduced
37
Closed
5

Top Buys

1
CLB icon
Core Laboratories
CLB
+$2.04M
2
VSTO
Vista Outdoor Inc.
VSTO
+$1.95M
3
CL icon
Colgate-Palmolive
CL
+$536K
4
ROL icon
Rollins
ROL
+$529K
5
DHR icon
Danaher
DHR
+$529K

Top Sells

1
TTC icon
Toro Company
TTC
+$9.03M
2
AMGN icon
Amgen
AMGN
+$8.9M
3
AON icon
Aon
AON
+$1.61M
4
KDP icon
Keurig Dr Pepper
KDP
+$1.5M
5
DLX icon
Deluxe
DLX
+$1.35M

Sector Composition

1 Consumer Discretionary 19.36%
2 Industrials 17.24%
3 Technology 16.87%
4 Consumer Staples 13.73%
5 Healthcare 12.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLX icon
26
Deluxe
DLX
$1.22B
$6.31M 1.79%
95,124
-21,287
-18% -$1.35M
PKG icon
27
Packaging Corp of America
PKG
$20.9B
$5.97M 1.69%
89,260
-359
-0.4% -$23.4K
NVO
28
Novo Nordisk
NVO
$228B
$5.89M 1.67%
219,160
-18,906
-8% -$518K
PII icon
29
Polaris
PII
$4.2B
$5.81M 1.65%
71,053
-2
-0% -$177
VAR
30
DELISTED
Varian Medical Systems, Inc.
VAR
$5.7M 1.62%
79,046
-3,398
-4% -$246K
SLGN icon
31
Silgan Holdings
SLGN
$5.01B
$5.4M 1.53%
209,990
+2,894
+1% +$74.4K
SYK icon
32
Stryker
SYK
$127B
$5.34M 1.51%
44,579
+1,448
+3% +$162K
EV
33
DELISTED
Eaton Vance Corp.
EV
$5.29M 1.5%
149,784
+3,831
+3% +$134K
K
34
DELISTED
Kellanova
K
$5.21M 1.48%
68,032
+2,279
+3% +$164K
ORLY icon
35
O'Reilly Automotive
ORLY
$71.5B
$5.2M 1.47%
287,580
-45,420
-14% -$803K
CNI icon
36
Canadian National Railway
CNI
$77.8B
$4.24M 1.2%
71,855
-6,193
-8% -$374K
ABBV icon
37
AbbVie
ABBV
$449B
$4.21M 1.19%
68,065
+1,880
+3% +$115K
VSTO
38
DELISTED
Vista Outdoor Inc.
VSTO
$3.62M 1.03%
75,922
+40,310
+113% +$1.95M
COL
39
DELISTED
Rockwell Collins
COL
$3.5M 0.99%
41,060
+690
+2% +$61.5K
DHR icon
40
Danaher
DHR
$145B
$3.4M 0.96%
50,089
+8,086
+19% +$529K
KMB icon
41
Kimberly-Clark
KMB
$36.2B
$3.18M 0.9%
23,151
+613
+3% +$80.2K
PDCO
42
DELISTED
Patterson Companies, Inc.
PDCO
$3.12M 0.89%
65,237
+3,810
+6% +$176K
OA
43
DELISTED
Orbital ATK, Inc.
OA
$3.07M 0.87%
36,054
+4,031
+13% +$352K
HBI
44
DELISTED
Hanesbrands
HBI
$2.93M 0.83%
116,453
-21,854
-16% -$596K
LH icon
45
Labcorp
LH
$23.1B
$2.73M 0.77%
24,434
+513
+2% +$55.2K
LLY icon
46
Eli Lilly
LLY
$1.04T
$2.41M 0.68%
30,630
+1,441
+5% +$108K
TECH icon
47
Bio-Techne
TECH
$11.2B
$2.16M 0.61%
76,688
+12,156
+19% +$312K
EXPD icon
48
Expeditors International
EXPD
$23.8B
$2.14M 0.61%
43,723
+301
+0.7% +$14.6K
CLB icon
49
Core Laboratories
CLB
$530M
$2.09M 0.59%
+16,873
New +$2.04M
MDT icon
50
Medtronic
MDT
$107B
$2.06M 0.58%
23,774
+2,246
+10% +$182K
1
2
3

Similar funds

AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
FCM
Fourpath Capital Management Oklahoma City, Oklahoma $697M AUM 29.98% 1-Year Est. Return
GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

JLB & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, JLB & Associates held 76 positions worth $353M, down 9.8% from $391M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

JLB & Associates withdrew a net $19.5M in Q2 2016, closing 5 positions and reducing 37 holdings. Its most notable exit was Amgen, an estimated $8.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

Against the trend, JLB & Associates opened a new position in Core Laboratories worth $2.09M.

  • JLB & Associates's largest Q2 2016 buy was Core Laboratories: 16,873 shares worth $2.09M.
  • JLB & Associates added most to Vista Outdoor Inc. in Q2 2016, an estimated $1.95M increase.
  • JLB & Associates's biggest Q2 2016 reduction was Toro Company, cutting an estimated $9.03M.
  • JLB & Associates fully exited Amgen in Q2 2016, selling an estimated $8.9M.
  • JLB & Associates's ten largest holdings make up 30% of its $353M portfolio in Q2 2016.
  • JLB & Associates opened 2 new positions and closed 5 in Q2 2016.
  • JLB & Associates's portfolio value fell 9.8% quarter-over-quarter to $353M.

Based on JLB & Associates's 13F filing for Q2 2016, filed 21 Jul 2016.